FDA Inspection 1195580 — Department of Defense - Naval Hospital Camp Pendleton
The FDA completed an inspection of Department of Defense - Naval Hospital Camp Pendleton on January 23, 2023 in Camp Pendleton, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 23, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Camp Pendleton, CA (United States)